Coronary MR Imaging: Effect of Timing and Dose of Isosorbide Dinitrate Administration

Coronary MR Imaging: Effect of Timing and Dose of Isosorbide Dinitrate Administration
复制标题

DOI:
10.1148/radiol.09090483
复制
发表时间:
2010-02-01
期刊:
影响因子:
19.7
通讯作者:
Nezafat, Reza
Nezafat, Reza
中科院分区:
医学1区
文献类型:
--
作者:
Hu, Peng;Chuang, Michael L.;Nezafat, Reza

文献摘要

被引文献

相似文献

目的:量化舌下硝酸异山梨酯(ISDN)管理冠状动脉磁共振(MR)imaging.Materials and Methods的影响:书面知情同意书,从所有参与者,并通过机构审查委员会批准了符合健康保险责任法案的协议。应用ISDN前后在1.5T条件下进行冠状动脉MR成像(2.5或5 mg),25名健康成人志愿者(平均年龄:23岁± 4岁; 9名男性,16名女性),(n = 20,随机分为四组)或全心脏(n = 5)采集梯度回波(GRE)或平衡稳态自由进动(SSFP)序列。图像质量由两名心脏病专家在四分量表上进行评估。对信噪比(SNR)、血管直径和血管清晰度进行了表征。采用线性混合效应模型进行数据分析。P值小于0.05被认为是指示显著差异。结果:5 mg ISDN的最大SNR增强(GRE:22.0% +/- 10.7%; SSFP:20.1% +/- 6.0%)与2.5 mg(GRE:21.9% +/- 5.4%; SSFP:19.1% +/- 3.0%)相似(P > .05)。然而,5 mg剂量达到最大SNR增强的时间(15.5分钟+/- 6.0)比2.5 mg剂量(23.5分钟+/- 6.7)更早(P <0.01)。5 mg ISDN组血管直径的增加大于2.5 mg ISDN组(GRE和SSFP序列均P <0.05)。应用ISDN后冠状动脉图像更清晰(P < .03)。在ISDN给药后,GRE图像的主观图像质量评分显著改善(两种剂量P <0.05),但SSFP图像相似(2.5 mg P = 0.24; 5 mg P = 0.27)。结论:舌下含服ISDN可提高冠状动脉MR成像信噪比。医师在进行冠状动脉MR成像时需要考虑ISDN的剂量和时间效应。
Purpose: To quantify the effect of sublingual isosorbide dinitrate ( ISDN) administration on coronary magnetic resonance (MR) imaging.Materials and Methods: Written informed consent was obtained from all participants, and the HIPAA-compliant protocol was approved by the Institutional Review Board. Coronary MR imaging was performed at 1.5 T before and after administration of ISDN (2.5 or 5 mg) in 25 healthy adult volunteers (mean age, 23 years +/- 4; nine men, 16 women) with three-dimensional targeted (n = 20, randomized into four groups) or whole-heart ( n = 5) acquisitions with gradient-recalled echo (GRE) or balanced steady-state free precession (SSFP) sequences. Image quality was assessed by two cardiologists on a four-point scale. Signal-to-noise ratio (SNR), vessel diameter, and vessel sharpness were characterized. A linear mixed-effects model was used for data analysis. A P value of less than .05 was considered to indicate a significant difference.Results: The maximum SNR enhancement with 5 mg of ISDN (GRE: 22.0% +/- 10.7%; SSFP: 20.1% +/- 6.0%) was similar (P > .05) to that with 2.5 mg (GRE: 21.9% +/- 5.4%; SSFP: 19.1% +/- 3.0%). However, the time to maximum SNR enhancement for the 5-mg dose (15.5 minutes +/- 6.0) was earlier (P < .01) than that for 2.5 mg (23.5 minutes +/- 6.7). The increase in vessel diameter with 5 mg of ISDN was greater than that with 2.5 mg (P < .05 for both GRE and SSFP sequences). The coronary images were sharper after ISDN administration (P < .03). Subjective image quality score significantly improved after ISDN administration for GRE images (P < .05 for both doses) but was similar for SSFP images (P = .24 for 2.5 mg; P = .27 for 5 mg). Whole-heart coronary SNR was improved about 10% after ISDN administration (P < .05).Conclusion: Sublingual ISDN improves coronary MR imaging SNR. Practitioners need to consider the dose and temporal effects of ISDN when performing coronary MR imaging.